Inflammatory Mechanisms in Post-Traumatic Stress Disorders

Post-traumatic stress disorder (PTSD) is increasingly recognised as a multisystem condition in which dysregulated immune and inflammatory processes contribute to both psychiatric symptoms and physical comorbidity. Traumatic stress provokes activation of the hypothalamic–pituitary–adrenal axis and sympathetic nervous system, leading to altered glucocorticoid sensitivity and heightened catecholamine release. These neuroendocrine changes promote a state of low-grade systemic inflammation, marked by elevated pro-inflammatory cytokines, oxidative stress and immune cell priming. Within the central nervous system, microglial cells adopt an activated phenotype, releasing inflammatory mediators that can disrupt synaptic plasticity and exacerbate fear circuitry in the amygdala, hippocampus and prefrontal cortex. Peripheral blood mononuclear cells exhibit epigenetic modifications that sustain inflammatory gene expression, linking early trauma to long-term immune dysregulation. This confluence of central and peripheral inflammatory pathways underlies comorbid cardiovascular, metabolic and neurodegenerative disorders observed in PTSD cohorts. Insights into these mechanisms have paved the way for the development of targeted anti-inflammatory and immunomodulatory interventions, as well as biomarker panels to guide personalised treatment strategies and improve long-term health outcomes.

Research from Nature Portfolio

Integrated analyses of RNA sequencing, microRNA profiling and DNA methylation in peripheral blood mononuclear cells have revealed that epigenetic alterations drive sustained upregulation of immune-related genes in PTSD patients. A seminal study demonstrated that reduced expression of key microRNAs is inversely correlated with enhanced transcription of pro-inflammatory pathways, while differential DNA methylation further reinforces cytokine gene activation. This holistic multi-omic approach has identified novel candidate regulators of chronic inflammation, highlighting epigenetic modulation as both a mechanistic link to trauma exposure and a potential therapeutic target for restoring immune homeostasis.

Inflammatory Mechanisms in Post-Traumatic Stress Disorders publication trend

The graph below shows the total number of articles in inflammatory mechanisms in post-traumatic stress disorders across all publications each year (not limited to Nature Index journals).

Technical terms

Cytokines: Small secreted proteins (for example interleukins and tumour necrosis factor) that modulate immune and inflammatory responses.
Peripheral blood mononuclear cells (PBMCs): A mixture of lymphocytes and monocytes isolated from blood, commonly used to study systemic immune activity.
Epigenetic regulation: Heritable changes in gene expression that occur without alterations to the DNA sequence, including DNA methylation and histone modification.
microRNA (miRNA): Short non-coding RNA molecules that post-transcriptionally regulate gene expression by binding to messenger RNA and inhibiting translation.
Microglia: Resident immune cells of the central nervous system that, when activated, release pro-inflammatory mediators and contribute to neuroinflammation.

References

1. Integrated analysis of proteomics, epigenomics and metabolomics data revealed divergent pathway activation patterns in the recent versus chronic post-traumatic stress disorder. Brain Behavior and Immunity (2023).
2. Psychological and biological mechanisms linking trauma with cardiovascular disease risk. Translational Psychiatry (2023).
3. Multi-omic biomarker identification and validation for diagnosing warzone-related post-traumatic stress disorder. Molecular Psychiatry (2019).
4. Dysregulated immune system networks in war veterans with PTSD is an outcome of altered miRNA expression and DNA methylation. Scientific Reports (2016).
5. Microglial deletion and inhibition alleviate behavior of post-traumatic stress disorder in mice. Journal of Neuroinflammation (2021).